Intrinsic Value

The intrinsic value of Britannia Life Sciences Inc (L020) under the Base Case is 0.005 EUR per share. Compared with the current market price of 0.026 EUR, the stock appears Overvalued by 82% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

L020 Intrinsic Value
€0.005
Overvaluation 82%
Intrinsic Value
Price €0.026
B

L020 is more expensive than usual. It was this expensive or more expensive on just 19% of days in the past 5 years.

Monitor L020
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0
Get notified when the price drops into your buy zone
Current Price €0.03
Intrinsic Value €0
Margin of Safety 20% €0
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to L020

Fundamental Analysis

What Britannia Life Sciences Does

Britannia Life Sciences Inc. is a laboratory and testing services company. It helps makers of health, wellness, and cannabis products check what is in their products, confirm quality, and meet regulatory requirements. In simple terms, it acts as a third-party lab that verifies whether products are safe, consistent, and properly labeled.

Headquarters
Canada CA
IPO date
Dec 1, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Britannia Life Sciences Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one L020 stock?

The intrinsic value for Britannia Life Sciences Inc (L020) under the Base Case is 0.005 EUR.

Is L020 stock undervalued or overvalued?

Compared with the current market price of 0.026 EUR, the stock appears Overvalued by 82% .

Back to Top